SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Tyler L. Harris, Colin A. Lowery, Mark S. Hixon, Kim D. Janda, A Platform Stratifying a Sequestering Agent and a Pharmacological Antagonist as a Means to Negate Botulinum Neurotoxicity, ACS Chemical Neuroscience, 2014, 140711063626006

    CrossRef

  2. 2
    Paul T. Bremer, Mark S. Hixon, Kim D. Janda, Benzoquinones as inhibitors of botulinum neurotoxin serotype A, Bioorganic & Medicinal Chemistry, 2014,

    CrossRef

  3. 3
    Dejan Caglič, Michelle C. Krutein, Kristin M. Bompiani, Deborah J. Barlow, Galit Benoni, Jeffrey C. Pelletier, Allen B. Reitz, Luke L. Lairson, Karen L. Houseknecht, Garry R. Smith, Tobin J. Dickerson, Identification of Clinically Viable Quinolinol Inhibitors of Botulinum Neurotoxin A Light Chain, Journal of Medicinal Chemistry, 2014, 57, 3, 669

    CrossRef

  4. 4
    Milica Videnović, Dejan M. Opsenica, James C. Burnett, Laura Gomba, Jonathan E. Nuss, Života Selaković, Jelena Konstantinović, Maja Krstić, Sandra Šegan, Mario Zlatović, Richard J. Sciotti, Sina Bavari, Bogdan A. Šolaja, Second Generation Steroidal 4-Aminoquinolines Are Potent, Dual-Target Inhibitors of the Botulinum Neurotoxin Serotype A Metalloprotease andP. falciparumMalaria, Journal of Medicinal Chemistry, 2014, 57, 10, 4134

    CrossRef

  5. 5
    Hajime Seki, Sabine Pellett, Peter Šilhár, G. Neil Stowe, Beatriz Blanco, Matthew A. Lardy, Eric A. Johnson, Kim D. Janda, Synthesis/biological evaluation of hydroxamic acids and their prodrugs as inhibitors for Botulinum neurotoxin A light chain, Bioorganic & Medicinal Chemistry, 2014, 22, 3, 1208

    CrossRef

  6. 6
    Igor M. Opsenica, Mikloš Tot, Laura Gomba, Jonathan E. Nuss, Richard J. Sciotti, Sina Bavari, James C. Burnett, Bogdan A. Šolaja, 4-Amino-7-chloroquinolines: Probing Ligand Efficiency Provides Botulinum Neurotoxin Serotype A Light Chain Inhibitors with Significant Antiprotozoal Activity, Journal of Medicinal Chemistry, 2013, 56, 14, 5860

    CrossRef

  7. 7
    Peter Šilhár, Matthew A. Lardy, Mark S. Hixon, Charles B. Shoemaker, Joseph T. Barbieri, Anjali K. Struss, Jenny M. Lively, Sacha Javor, Kim D. Janda, C-Terminus of Botulinum A Protease Has Profound and Unanticipated Kinetic Consequences upon the Catalytic Cleft, ACS Medicinal Chemistry Letters, 2013, 4, 2, 283

    CrossRef

  8. 8
    Peter Šilhár, Nicholas R. Silvaggi, Sabine Pellett, Kateřina Čapková, Eric A. Johnson, Karen N. Allen, Kim D. Janda, Evaluation of adamantane hydroxamates as botulinum neurotoxin inhibitors: Synthesis, crystallography, modeling, kinetic and cellular based studies, Bioorganic & Medicinal Chemistry, 2013, 21, 5, 1344

    CrossRef

  9. 9
    C. Lungu, E. Considine, S. Zahir, B. Ponsati, S. Arrastia, M. Hallett, Pilot study of topical acetyl hexapeptide-8 in the treatment for blepharospasm in patients receiving botulinum toxin therapy, European Journal of Neurology, 2013, 20, 3
  10. 10
    Colin A. Lowery, Michael Adler, Andrew Borrell, Kim D. Janda, Scorpion toxins for the reversal of BoNT-induced paralysis, Bioorganic & Medicinal Chemistry Letters, 2013, 23, 24, 6743

    CrossRef

  11. 11
    Peter Šilhár, Lisa M. Eubanks, Hajime Seki, Sabine Pellett, Sacha Javor, William H. Tepp, Eric A. Johnson, Kim D. Janda, Targeting Botulinum A Cellular Toxicity: A Prodrug Approach, Journal of Medicinal Chemistry, 2013, 56, 20, 7870

    CrossRef

  12. 12
    Dejan Caglič, Tobin J Dickerson, A coincidence detector triggers botulinum neurotoxin translocation, Future Microbiology, 2012, 7, 2, 185

    CrossRef

  13. 13
    Garry R. Smith, Dejan Caglič, Petr Čapek, Yan Zhang, Sujata Godbole, Allen B. Reitz, Tobin J. Dickerson, Reexamining hydroxamate inhibitors of botulinum neurotoxin serotype A: Extending towards the β-exosite, Bioorganic & Medicinal Chemistry Letters, 2012, 22, 11, 3754

    CrossRef

  14. 14
    Igor Opsenica, Vuk Filipovic, Jon E. Nuss, Laura M. Gomba, Dejan Opsenica, James C. Burnett, Rick Gussio, Bogdan A. Solaja, Sina Bavari, The synthesis of 2,5-bis(4-amidinophenyl)thiophene derivatives providing submicromolar-range inhibition of the botulinum neurotoxin serotype A metalloprotease, European Journal of Medicinal Chemistry, 2012, 53, 374

    CrossRef

  15. 15
    Nicholas T. Salzameda, Lisa M. Eubanks, Joseph S. Zakhari, Kyoji Tsuchikama, Nicholas J. DeNunzio, Karen N. Allen, Mark S. Hixon, Kim D. Janda, A cross-over inhibitor of the botulinum neurotoxin light chain B: a natural product implicating an exosite mechanism of action, Chemical Communications, 2011, 47, 6, 1713

    CrossRef

  16. 16
    Joseph S. Zakhari, Isao Kinoyama, Mark S. Hixon, Antonia Di Mola, Daniel Globisch, Kim D. Janda, Formulating a new basis for the treatment against botulinum neurotoxin intoxication: 3,4-Diaminopyridine prodrug design and characterization, Bioorganic & Medicinal Chemistry, 2011, 19, 21, 6203

    CrossRef

  17. 17
    Aaron A. Thompson, Guan-Sheng Jiao, Seongjin Kim, April Thai, Lynne Cregar-Hernandez, Stephen A. Margosiak, Alan T. Johnson, Gye Won Han, Sean O’Malley, Raymond C. Stevens, Structural Characterization of Three Novel Hydroxamate-Based Zinc Chelating Inhibitors of theClostridium botulinumSerotype A Neurotoxin Light Chain Metalloprotease Reveals a Compact Binding Site Resulting from 60/70 Loop Flexibility, Biochemistry, 2011, 50, 19, 4019

    CrossRef

  18. 18
    Peter Šilhár, Sami Alakurtti, Kateřina Čapková, Feng Xiaochuan, Charles B. Shoemaker, Jari Yli-Kauhaluoma, Kim D. Janda, Synthesis and evaluation of library of betulin derivatives against the botulinum neurotoxin A protease, Bioorganic & Medicinal Chemistry Letters, 2011, 21, 8, 2229

    CrossRef

  19. 19
    Xiao Feng Fang, Zong Jie Cui, The Anti-Botulism Triterpenoid Toosendanin Elicits Calcium Increase and Exocytosis in Rat Sensory Neurons, Cellular and Molecular Neurobiology, 2011, 31, 8, 1151

    CrossRef

  20. 20
    Kateřina Čapková, Mark S. Hixon, Sabine Pellett, Joseph T. Barbieri, Eric A. Johnson, Kim D. Janda, Benzylidene cyclopentenediones: First irreversible inhibitors against botulinum neurotoxin A’s zinc endopeptidase, Bioorganic & Medicinal Chemistry Letters, 2010, 20, 1, 206

    CrossRef

  21. 21
    Peter Šilhár, Kateřina Čapková, Nicholas T. Salzameda, Joseph T. Barbieri, Mark S. Hixon, Kim D. Janda, Botulinum Neurotoxin A Protease: Discovery of Natural Product Exosite Inhibitors, Journal of the American Chemical Society, 2010, 132, 9, 2868

    CrossRef

  22. 22
    Pål Stenmark, Min Dong, Jérôme Dupuy, Edwin R. Chapman, Raymond C. Stevens, Crystal Structure of the Botulinum Neurotoxin Type G Binding Domain: Insight into Cell Surface Binding, Journal of Molecular Biology, 2010, 397, 5, 1287

    CrossRef

  23. 23
    Ramin Mollaaghababa Hakami, Gordon Ruthel, Andrea M. Stahl, Sina Bavari, Gaining ground: assays for therapeutics against botulinum neurotoxin, Trends in Microbiology, 2010, 18, 4, 164

    CrossRef

  24. 24
    Matthew J. Saunders, Steven W. Graves, Larry A. Sklar, Tudor I. Oprea, Bruce S. Edwards, High-Throughput Multiplex Flow Cytometry Screening for Botulinum Neurotoxin Type A Light Chain Protease Inhibitors, ASSAY and Drug Development Technologies, 2010, 8, 1, 37

    CrossRef

  25. 25
    S Ramasamy, CQ Liu, H Tran, A Gubala, P Gauci, J McAllister, T Vo, Principles of antidote pharmacology: an update on prophylaxis, post-exposure treatment recommendations and research initiatives for biological agents, British Journal of Pharmacology, 2010, 161, 4
  26. 26
    Yuya Nakai, Sabine Pellett, William H. Tepp, Eric A. Johnson, Kim D. Janda, Toosendanin: Synthesis of the AB-ring and investigations of its anti-botulinum properties (Part II), Bioorganic & Medicinal Chemistry, 2010, 18, 3, 1280

    CrossRef

  27. 27
    A. Fischer, Y. Nakai, L. M. Eubanks, C. M. Clancy, W. H. Tepp, S. Pellett, T. J. Dickerson, E. A. Johnson, K. D. Janda, M. Montal, Bimodal modulation of the botulinum neurotoxin protein-conducting channel, Proceedings of the National Academy of Sciences, 2009, 106, 5, 1330

    CrossRef

  28. 28
    Scott T. Moe, Andrew B. Thompson, Genessa M. Smith, Ross A. Fredenburg, Ross L. Stein, Alan R. Jacobson, Botulinum neurotoxin serotype A inhibitors: Small-molecule mercaptoacetamide analogs, Bioorganic & Medicinal Chemistry, 2009, 17, 8, 3072

    CrossRef

  29. 29
    Bert Willis, Lisa M. Eubanks, Tobin J. Dickerson, Kim D. Janda, ChemInform Abstract: The Strange Case of the Botulinum Neurotoxin: Using Chemistry and Biology to Modulate the Most Deadly Poison, ChemInform, 2009, 40, 3
  30. 30
    M. J. Fagerlund, L. I. Eriksson, Current concepts in neuromuscular transmission, British Journal of Anaesthesia, 2009, 103, 1, 108

    CrossRef

  31. 31
    Xuerong Shi, Gregory E. Garcia, Roger J. Neill, Richard K. Gordon, TCEP treatment reduces proteolytic activity of BoNT/B in human neuronal SHSY-5Y cells, Journal of Cellular Biochemistry, 2009, 107, 5
  32. 32
    Xuerong Shi, Jennifer E. Curran, Zhilin Liao, Richard K. Gordon, The biological activity of ubiquitinated BoNT/B light chain in vitro and in human SHSY-5Y neuronal cells, Journal of Cellular Biochemistry, 2009, 108, 3